-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Lipella Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q2 2024.
- Lipella Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$938K, a 39% increase year-over-year.
- Lipella Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$4.14M, a 12.4% decline year-over-year.
- Lipella Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.62M, a 77.8% decline from 2022.
- Lipella Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.6M, a 39.3% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)